首頁 > 市場調查報告書 > 製藥

再生醫學細胞療法

市場調查報告書

商品編碼

1490005

細胞療法製造市場：按治療類型、按技術類型、按製造目的、按應用、按地區

Cell Therapy Manufacturing Market, By Therapy Type, By Technology Type, By Manufacturing Purpose, By Application, By Geography

出版日期: 2024年05月07日 | 出版商:

Coherent Market Insights | 英文 205 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024年全球細胞療法製造市場價值為49.1億美元，預計到2031年將達到129.6億美元，2024年至2031年的年複合成長率為14.9%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	49.1億美元
實際資料	2019-2023	預測期	2024-2031
2024-2031 年預測期間的年複合成長率：	14.90%	2031 年金額預測	129.6億美元

圖：2024 年按地區分類的細胞療法製造市場佔有率 (%)

近年來，由於心臟疾病等慢性疾病的盛行率不斷上升，全球細胞療法製造市場出現了顯著成長。與傳統藥物相比，細胞療法是針對多種病症更有效的治療選擇。細胞治療製造技術的進步和政府對細胞研究的支持，特別是在美國和歐洲，預計將在預測期內推動市場成長。然而，與細胞療法開發和製造相關的高成本可能會阻礙市場成長。

市場動態：

全球細胞療法製造市場的成長是由心臟疾病等慢性疾病日益普及所推動的。細胞療法製造技術的進步實現了高效、大規模生產，這是市場成長的驅動力。主要市場的各國政府正在透過財政支持和監管指南來支持細胞研究，這為市場參與者提供了機會。然而，細胞療法從實驗室開發到商業化的高成本可能會阻礙市場成長。參與企業需要巨額資本投資，這阻礙了市場的成長。缺乏熟練的細胞處理專家也阻礙了市場的成長。公司之間持續的併購在不久的將來提供了潛在的成長機會。

本研究的主要特點

該報告對全球細胞療法製造市場進行了詳細分析，並提出了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。
它還揭示了各個細分市場的潛在收益成長機會，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
根據公司亮點、產品系列、主要亮點、績效和策略等參數對全球細胞療法製造市場的主要企業進行了分析。
主要企業包括WuXi AppTec, Inc.Lonza、Merck KGaA、Takara Bio Inc.、Sumitomo Dainippon Pharma Co., LTD.、Fujifilm Holdings Corporation、Thermo Fisher Scientific, Inc.、Astellas Pharma Inc.、OXGENE、Cytiva、Exothera、Charles River Laboratories、Cell Therapies Pty Ltd、Bio-Techne 和Catalent, Inc.
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球細胞療法製造市場迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球細胞治療製造市場的各種策略矩陣來促進他們的決策。

公司簡介
- WuXi AppTec, Inc.
- Lineage Cell Therapeutics, Inc.
- Healios Ltd.
- Lonza
- Merck KGaA
- Takara Bio Inc.
- Sumitomo Dainippon Pharma Co., LTD.
- Fujifilm Holdings Corporation
- Thermo Fisher Scientific, Inc.
- Astellas Pharma Inc.
- OXGENE
- Cytiva
- Exothera
- Charles River Laboratories
- Cell Therapies Pty Ltd
- Bio-Techne
- Catalent, Inc

第11章分析師建議

命運之輪
分析師觀點
Coherent Opportunity Map

第12章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI1728

Global cell therapy manufacturing market is estimated to be valued at USD 4.91 Bn in 2024 and is expected to reach USD 12.96 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 14.9% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 4.91 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	14.90%	2031 Value Projection:	US$ 12.96 Bn

Figure. Cell Therapy Manufacturing Market Share (%), By Region, 2024

Cell Therapy Manufacturing Market - IMG1

Global cell therapy manufacturing market has been witnessing significant growth in the recent years, owing to growing prevalence of chronic diseases such as cancer and cardiac disorders. Cell therapies are more effective treatment options for various conditions as compared to traditional drugs. The advancement in cell therapy manufacturing technology and government support for cell-based research especially in the U.S. and Europe are projected to drive the market growth during the forecast period. However, high costs associated with cell therapy development and manufacturing can hamper the market growth.

Market Dynamics:

Global cell therapy manufacturing market growth is driven by growing prevalence of chronic diseases such as cancer and cardiac disorders. Advancements in cell therapy manufacturing technologies enable efficient and large-scale production, and this drives the market growth. Various governments across major markets are supporting cell-based research through funding and regulatory guidelines, and this offers opportunities for market players. However, high costs associated with cell therapy development from laboratory to commercialization can hamper the growth of market. Market players require huge capital investments, and this hampers the market growth. Lack of skilled professionals for cell processing also hampers the market growth. Ongoing mergers and acquisitions among players provides potential growth opportunities in the near future.

Key Features of the Study:

This report provides an in-depth analysis of the global cell therapy manufacturing market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global cell therapy manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes WuXi AppTec, Inc., Lineage Cell Therapeutics, Inc., Healios Ltd. , Lonza, Merck KGaA, Takara Bio Inc., Sumitomo Dainippon Pharma Co., LTD., Fujifilm Holdings Corporation, Thermo Fisher Scientific, Inc., Astellas Pharma Inc., OXGENE, Cytiva, Exothera, Charles River Laboratories, Cell Therapies Pty Ltd, Bio-Techne, Catalent, Inc
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global cell therapy manufacturing market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell therapy manufacturing market.

Detailed Segmentation-

By Therapy Type:
- Allogeneic Cell Therapy
- Autologous Cell Therapy
By Technology Type:
- Somatic Cell Technology
- Cell Immortalization Technology
- Viral Vector Technology
- Genome Editing Technology
- Cell Plasticity Technology
- 3D Technology
By Manufacturing Purpose:
- Clinical
- Commercial
- Pre-clinical
By Application:
- Musculoskeletal
- Cardiovascular
- Gastrointestinal
- Neurological
- Oncology
- Dermatology
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- WuXi AppTec, Inc.
- Lineage Cell Therapeutics, Inc.
- Healios Ltd.
- Lonza
- Merck KGaA
- Takara Bio Inc.
- Sumitomo Dainippon Pharma Co., LTD.
- Fujifilm Holdings Corporation
- Thermo Fisher Scientific, Inc.
- Astellas Pharma Inc.
- OXGENE
- Cytiva
- Exothera
- Charles River Laboratories
- Cell Therapies Pty Ltd
- Bio-Techne
- Catalent, Inc

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Therapy Type
- Market Snapshot, By Technology Type
- Market Snapshot, By Manufacturing Purpose
- Market Snapshot, By Application
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Cell Therapy Manufacturing Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Cell Therapy Manufacturing Market, By Therapy Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Allogeneic Cell Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Autologous Cell Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Cell Therapy Manufacturing Market, By Technology Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Somatic Cell Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cell Immortalization Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Viral Vector Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Genome Editing Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cell Plasticity Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
3D Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Cell Therapy Manufacturing Market, By Manufacturing Purpose, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Clinical
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Commercial
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Pre-clinical
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Cell Therapy Manufacturing Market, By Application, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Musculoskeletal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cardiovascular
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Gastrointestinal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Neurological
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Dermatology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Cell Therapy Manufacturing Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Purpose, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
  - Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Purpose, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
  - Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Purpose, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
  - Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Purpose, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
  - Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Purpose, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Purpose, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

10. Competitive Landscape

Company Profiles
- WuXi AppTec, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Lineage Cell Therapeutics, Inc.
- Healios Ltd.
- Lonza
- Merck KGaA
- Takara Bio Inc.
- Sumitomo Dainippon Pharma Co., LTD.
- Fujifilm Holdings Corporation
- Thermo Fisher Scientific, Inc.
- Astellas Pharma Inc.
- OXGENE
- Cytiva
- Exothera
- Charles River Laboratories
- Cell Therapies Pty Ltd
- Bio-Techne
- Catalent, Inc